Auditor

SF Revision Sàrl is appointed as Auditor of Alithea Genomics SA.

Financing

The share capital of Alithea Genomics SA is increased to CHF CHF 201,804, divided into 100,000 registered common shares of CHF 1 and 101,804 preferred registered shares as to liquidation proceeds of C…

Capital increase

New fully paid-up share capital: CHF 100,000 divided into 100,000 registered shares of CHF 1, with transfer restrictions as per the Articles of Association. Ordinary capital increase, in cash and by o…

Board Composition

Mr. Jan Van den Berghe is appointed as new member of the Board of Alithea Genomics SA.

Board Composition

Mr. Roger Küng is appointed as new member of the Board of Alithea Genomics SA.

Board Composition

Mr. Hans Binz is appointed as new member of the Board of Alithea Genomics SA.

Financing

The share capital of Alithea Genomics SA is increased to CHF 144,294, divided into 100,000 registered common shares of CHF 1 and 44,294 preferred registered shares as to liquidation proceeds of CHF 1,…

Board Composition

M. Riccardo Dainese is stepping down as Chairman of the Board and Frederik Decouttere is taking over the role.

Board Composition

Mr. Bart Deplancke is no longer member of the Board of Directors of Alithea Genomics SA.